European Radiology: About the malignantity of mumps lymphatic tissue-related lesions, let CT radiology tell you!
The independent medical imaging market is leading the way with 50 billion CT and MR
heard of virtual CT intestinal imaging as non-invasive?
Br J Cancer: Computer fault scanning (CT) has no advantage over chest XR in the initial assessment of pregnancy nourishing cell tumor formation
Euro Radio: Use CT texture analysis to discover the post-treatment response to liver cell liver cancer TACE!
Human erythrial chycodesome (CT) enzyme-linked immunoassitric analysis (ELISA)
experimental principle:
Grigg Ingeham and Click Therapeutics collaborated in the development and commercialization of CT-155. South Korea MFDS approves phase II/ III key trials of the anti-COVID-19 monoclonal antibody CT-P59. Blood: PET-CT guidance consolidates the effects of radiotherapy on long-term prognostication in patients with advanced DLBCL. The anti-COVID-19 monoclonal antibody candidate drug CT-P59:Phase I clinical trials obtained positive results. Comparison of methionine with fluorine thymus PET-CT diagnosis of IDH mutant glioma. "Macrophage immunotherapy" CT-0508 treatment of solid tumors: better than traditional cell therapy. Radiology: Coronary CT can be a stone with more than a bird! Lung embolism, cancer, osteoporosis can also be detected. Professor Zhang Xiao: For patients with hard skin, it is recommended to do high-resolution CT in the lungs once a year. Application of deep learning in CT images: The use of convolutional neural networks to automatically detect lung nodules for subsequent management. Nat Biomed Eng's new breakthrough! Systemic tracking of single cells with PET/CT imaging Philips Electronics develops a new CT scanner CT-guided fine needle suction to diagnose liver disease is highly accurate Standardized radiation dose of four-dimensional CT can reduce lung damage When did patients with mild cranial trauma who were initially CT-positive review CT? Time of Update: 2020-10-20
the drug began being reviewed by the FDA more than a decade ago, even though the original Phase 3 clinical trial did not reach its main end point.
Time of Update: 2020-10-02
Celltrion Group announced today that the Korean Ministry of Food and Drug Safety (MFDS) has approved the company's Application for Research New Drugs (IND) to allow the conduct of critical Phase II/III clinical trials against COVID-19 monoclonal
Time of Update: 2020-09-23
non-progressive PET-POS patients who received solid radiotherapy (109/206,53%) had a prognostic close proximity to PET-NEG patients, with 3-year TTP and OS estimates of 76% and 80%, respectively.
Time of Update: 2020-09-22
Celltrion, a pharmaceutical company, recently published the interim results of a Phase I clinical trial of CT-P59 (a drug candidate against COVID-19 monoclonal antibodies), which showed that CT-P59 has good safety, toerability and pharmacodynamics.
Time of Update: 2020-09-12
the average T/N ratio of IDH1 wild glioma FLT-PET/CT was significantly higher than that of IDH1 mutant glioma (P-0.005), but the met-PET/CT test results were not so.
Time of Update: 2020-07-30
based on the IND, CARISMA plans to initiate Phase I clinical trials for CT-0508 treatment for patients with recurrent or metastatic HER2 overexpression solid tumors.
Time of Update: 2020-07-30
the !---- coronary CT has gone beyond heart testing. a recent Danish study of 1,487 participants showed that checking the mineral density of the thoracic vertebrae "by the way" during routine coronary CT can help screening for osteoporosis
Time of Update: 2020-07-23
In September, the u.S. Drug Enforcement Administration approved Nedab's expansion of adaptation-specific pulmonary fibrosis (IPF) to SSc-ILD, the first and only drug to slow the decline in lung function in patients with SSc-ILD, based on data from the SENSCIS study.
Time of Update: 2020-07-17
The retrained CAD model and three radiologists with different levels of experience were analyzed in the test for free-response subjects' working characteristics curve (free-response receiver profile, FROC) to assess their detection effectiveness.
Time of Update: 2020-07-15
, July 9, 2020 / BiovalleyBIOON /- Living molecular imagery can detect the movement dynamics and movement of injected cells throughout the body, but most existing methods are unable to accurately assess cell distribution due
Time of Update: 2020-07-06
Philips Electronics recently developed a new CT scanner , not only can high-speed display of three-dimensional images of human organs, but also can greatly reduce radiation radiation to the human body.
Time of Update: 2020-07-06
In the study, Dr. Wu said, the CT-guided liver FNA diagnosis rate was 95 percent, sensitivity was 99 percent, and specificity was 100 percent.
Time of Update: 2020-07-06
four-dimensional CT (4D-CT) technology can track the of lung movement, which is beneficial to clinicians to reduce and optimize targeted radiotherapy and strengthen lung cancer treatment.
Time of Update: 2020-06-28
the authors, there was no significant benefit for patients with mild brain trauma who were positive in the initial CT scan and clinically stable.
Welcome to Echemi
